Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer

PURPOSE: Real‐world data about pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) are limited. We have aimed to highlight the role of PLD in daily practice focusing on older patients and patients with comorbidities with MBC. METHODS: We analyzed electronic records...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallrabenstein, T., Daetwyler, E., Oseledchyk, A., Rochlitz, C., Vetter, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315717/
https://www.ncbi.nlm.nih.gov/pubmed/37148541
http://dx.doi.org/10.1002/cam4.6041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315717/
https://www.ncbi.nlm.nih.gov/pubmed/37148541
http://dx.doi.org/10.1002/cam4.6041

Ejemplares similares